BioGaia AB, commonly referred to as BioGaia, is a leading biotechnology company headquartered in Sweden. Founded in 1990, the company has established itself as a pioneer in the development of probiotic products, focusing on gut health and overall well-being. With a strong presence in Europe, North America, and Asia, BioGaia operates within the health and wellness industry, specifically in the probiotics sector. The company’s core offerings include a range of probiotic supplements and functional foods, distinguished by their unique strains of Lactobacillus reuteri. BioGaia's commitment to scientific research and innovation has led to numerous key milestones, including partnerships with major global brands and a robust portfolio of clinical studies supporting their products. Recognised for its market leadership, BioGaia continues to enhance its reputation through ongoing advancements in probiotic technology and consumer education.
How does Biogaia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biogaia's score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, BioGaia AB, headquartered in Sweden, reported total greenhouse gas emissions of approximately 7,300,000 kg CO2e across all scopes. This includes 73,000 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and 33,000 kg CO2e from Scope 2 emissions, calculated on a market-based approach. The majority of their emissions, about 7,168,000 kg CO2e, stem from Scope 3 activities. Comparatively, in 2023, BioGaia's emissions were approximately 6,284,000 kg CO2e, with Scope 1 emissions at 77,000 kg CO2e and Scope 2 emissions at 32,000 kg CO2e. This indicates a significant increase in total emissions year-on-year, particularly in Scope 3. BioGaia has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions by 46% by 2030 from 2019 levels, as part of its Science Based Targets initiative (SBTi) commitments. The company is also working towards achieving near-zero emissions in both Scope 1 and Scope 2 by 2050. These targets reflect a long-term commitment to sustainability and align with global efforts to limit temperature rise to 1.5°C. Overall, BioGaia's emissions data and reduction targets highlight its proactive approach to addressing climate change, despite the recent increase in emissions. The company is focused on measuring and reducing its Scope 3 emissions as part of its comprehensive climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Scope 1 | 7,000 | 00,000 | - | 00,000 | 00,000 | 00,000 | 00,000 |
Scope 2 | 61,000 | 00,000 | 00,000 | 0,000 | 00,000 | 00,000 | 00,000 |
Scope 3 | 2,438,000 | 0,000,000 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biogaia is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.